37 related articles for article (PubMed ID: 33855323)
1. Lack of association of Stevens-Johnson syndrome/toxic epidermal necrolysis due to aromatic anticonvulsants and HLA-B alleles in South Indian children.
Srinivas SM; Gowda VK; Gowdra A; Gangasamudra Veerappa B; Kumar P
Int J Dermatol; 2024 May; 63(5):e97-e99. PubMed ID: 38415927
[No Abstract] [Full Text] [Related]
2. Carbamazepine-induced Stevens-Johnson syndrome progressing to toxic epidermal necrolysis: a rare clinical image.
Ralte R; Mendhe D
Pan Afr Med J; 2024; 47():44. PubMed ID: 38681105
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics to prevent hypersensitivity reactions to antiepileptic drugs: is testing performed when indicated?
Bui VL; Alvarez-Arango S; Stevenson JM
Pharmacogenet Genomics; 2024 Jan; 34(1):16-19. PubMed ID: 37830946
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrosis induced by carbamazepine embedded in the subcutis.
Liu JJ; Lu SC; Liu JL; Yang HM
An Bras Dermatol; 2018; 93(4):620-621. PubMed ID: 30066786
[No Abstract] [Full Text] [Related]
5. Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
Fukunaga K; Tsukagoshi E; Kurata M; Mizukawa Y; Niihara H; Morita E; Watanabe Y; Yamaguchi Y; Watanabe H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Azukizawa H; Asada H; Hasegawa A; Hama N; Ozeki T; Mashimo Y; Sekine A; Matsunaga K; Tanaka Y; Nakamura R; Abe R; Mushiroda T; Saito Y
J Invest Dermatol; 2024 Apr; 144(4):908-911.e7. PubMed ID: 37914023
[No Abstract] [Full Text] [Related]
6. Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis.
Qiumei G; Zhengju C; Xuefei H; Qu C
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36572447
[TBL] [Abstract][Full Text] [Related]
7. Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.
Wang Q; Sun S; Xie M; Zhao K; Li X; Zhao Z
Epilepsy Res; 2017 Sep; 135():19-28. PubMed ID: 28618376
[TBL] [Abstract][Full Text] [Related]
8. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
[TBL] [Abstract][Full Text] [Related]
9. A marker for Stevens-Johnson syndrome ...: ethnicity matters.
Lonjou C; Thomas L; Borot N; Ledger N; de Toma C; LeLouet H; Graf E; Schumacher M; Hovnanian A; Mockenhaupt M; Roujeau JC;
Pharmacogenomics J; 2006; 6(4):265-8. PubMed ID: 16415921
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine-induced toxic epidermal necrolysis: the importance of HLA-B*1502 testing in at-risk populations prior to therapy initiation.
Sargent B; Juhasz MLW; Joe VC; Lee BA; Rojek NW
Int J Dermatol; 2021 Jul; 60(7):907-908. PubMed ID: 33608873
[No Abstract] [Full Text] [Related]
11. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
Tangamornsuksan W; Chaiyakunapruk N; Somkrua R; Lohitnavy M; Tassaneeyakul W
JAMA Dermatol; 2013 Sep; 149(9):1025-32. PubMed ID: 23884208
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.
Mehta TY; Prajapati LM; Mittal B; Joshi CG; Sheth JJ; Patel DB; Dave DM; Goyal RK
Indian J Dermatol Venereol Leprol; 2009; 75(6):579-82. PubMed ID: 19915237
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine-induced toxic epidermal necrolysis in a patient despite testing negative for HLA B*15:02 allele.
Jiang B; Oh CC; Tan KW; Lee HY
Ann Acad Med Singap; 2021 Mar; 50(3):258-260. PubMed ID: 33855323
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
